Annual CFO:
$479.06M+$90.49M(+23.29%)Summary
- As of today, HALO annual cash from operations is $479.06 million, with the most recent change of +$90.49 million (+23.29%) on December 31, 2024.
- During the last 3 years, HALO annual cash from operations has risen by +$179.62 million (+59.99%).
- HALO annual cash from operations is now at all-time high.
Performance
HALO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$99.71M-$54.51M(-35.35%)Summary
- As of today, HALO quarterly cash from operations is $99.71 million, with the most recent change of -$54.51 million (-35.35%) on June 30, 2025.
- Over the past year, HALO quarterly cash from operations has increased by +$43.92 million (+78.71%).
- HALO quarterly cash from operations is now -44.13% below its all-time high of $178.47 million, reached on December 31, 2024.
Performance
HALO Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$547.77M+$43.92M(+8.72%)Summary
- As of today, HALO TTM cash from operations is $547.77 million, with the most recent change of +$43.92 million (+8.72%) on June 30, 2025.
- Over the past year, HALO TTM cash from operations has increased by +$127.79 million (+30.43%).
- HALO TTM cash from operations is now at all-time high.
Performance
HALO TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
HALO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +23.3% | +78.7% | +30.4% |
| 3Y3 Years | +60.0% | +147.9% | +87.4% |
| 5Y5 Years | +660.8% | +2927.1% | +2579.6% |
HALO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +99.5% | -44.1% | +78.7% | at high | +128.1% |
| 5Y | 5-Year | at high | +660.8% | -44.1% | +1538.9% | at high | +2579.6% |
| All-Time | All-Time | at high | +660.8% | -44.1% | +437.0% | at high | +738.1% |
HALO Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $99.71M(-35.3%) | $547.77M(+8.7%) |
| Mar 2025 | - | $154.22M(-13.6%) | $503.86M(+5.2%) |
| Dec 2024 | $479.06M(+23.3%) | $178.47M(+54.7%) | $479.06M(+18.9%) |
| Sep 2024 | - | $115.38M(+106.8%) | $402.95M(-4.1%) |
| Jun 2024 | - | $55.79M(-56.9%) | $419.99M(-2.6%) |
| Mar 2024 | - | $129.43M(+26.5%) | $431.03M(+10.9%) |
| Dec 2023 | $388.57M(+61.8%) | $102.35M(-22.7%) | $388.57M(+5.4%) |
| Sep 2023 | - | $132.41M(+98.1%) | $368.67M(+20.5%) |
| Jun 2023 | - | $66.84M(-23.1%) | $305.89M(+9.5%) |
| Mar 2023 | - | $86.96M(+5.5%) | $279.28M(+16.3%) |
| Dec 2022 | $240.11M(-19.8%) | $82.45M(+18.4%) | $240.11M(-0.0%) |
| Sep 2022 | - | $69.64M(+73.1%) | $240.17M(-17.8%) |
| Jun 2022 | - | $40.23M(-15.8%) | $292.28M(+1.2%) |
| Mar 2022 | - | $47.80M(-42.1%) | $288.94M(-3.5%) |
| Dec 2021 | $299.44M(+440.0%) | $82.52M(-32.2%) | $299.44M(+11.8%) |
| Sep 2021 | - | $121.74M(+230.0%) | $267.84M(+76.0%) |
| Jun 2021 | - | $36.89M(-36.7%) | $152.19M(+28.3%) |
| Mar 2021 | - | $58.30M(+14.5%) | $118.59M(+113.9%) |
| Dec 2020 | $55.45M(+164.9%) | $50.92M(+736.9%) | $55.45M(+351.0%) |
| Sep 2020 | - | $6.08M(+84.7%) | -$22.09M(+61.8%) |
| Jun 2020 | - | $3.29M(+168.0%) | -$57.76M(+32.7%) |
| Mar 2020 | - | -$4.84M(+81.8%) | -$85.84M(-0.5%) |
| Dec 2019 | -$85.42M(-72.6%) | -$26.63M(+10.0%) | -$85.42M(-76.7%) |
| Sep 2019 | - | -$29.59M(-19.4%) | -$48.34M(-28.3%) |
| Jun 2019 | - | -$24.79M(-460.3%) | -$37.67M(-18.7%) |
| Mar 2019 | - | -$4.42M(-142.3%) | -$31.75M(+35.9%) |
| Dec 2018 | -$49.50M(-136.9%) | $10.46M(+155.3%) | -$49.50M(-153.1%) |
| Sep 2018 | - | -$18.93M(-0.4%) | $93.29M(-29.6%) |
| Jun 2018 | - | -$18.86M(+15.0%) | $132.47M(-1.4%) |
| Mar 2018 | - | -$22.18M(-114.5%) | $134.34M(+0.2%) |
| Dec 2017 | $134.05M(+366.1%) | $153.25M(+656.4%) | $134.05M(+483.4%) |
| Sep 2017 | - | $20.26M(+219.2%) | -$34.96M(+45.3%) |
| Jun 2017 | - | -$17.00M(+24.3%) | -$63.97M(-6.9%) |
| Mar 2017 | - | -$22.46M(-42.4%) | -$59.82M(-18.7%) |
| Dec 2016 | -$50.38M(-35.9%) | -$15.77M(-80.2%) | -$50.38M(-1.1%) |
| Sep 2016 | - | -$8.75M(+31.9%) | -$49.81M(+14.2%) |
| Jun 2016 | - | -$12.85M(+1.4%) | -$58.05M(-60.1%) |
| Mar 2016 | - | -$13.02M(+14.3%) | -$36.27M(+2.2%) |
| Dec 2015 | -$37.08M(+22.0%) | -$15.20M(+10.5%) | -$37.08M(-62.5%) |
| Sep 2015 | - | -$16.98M(-290.0%) | -$22.82M(-20.0%) |
| Jun 2015 | - | $8.94M(+164.6%) | -$19.02M(+56.5%) |
| Mar 2015 | - | -$13.84M(-1373.8%) | -$43.73M(+8.0%) |
| Dec 2014 | -$47.52M(+3.7%) | -$939.00K(+92.9%) | -$47.52M(+23.1%) |
| Sep 2014 | - | -$13.18M(+16.4%) | -$61.80M(-1.3%) |
| Jun 2014 | - | -$15.77M(+10.6%) | -$61.03M(-8.6%) |
| Mar 2014 | - | -$17.63M(-15.8%) | -$56.22M(-13.9%) |
| Dec 2013 | -$49.34M | -$15.22M(-22.6%) | -$49.34M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$12.41M(-13.3%) | -$50.99M(+3.6%) |
| Jun 2013 | - | -$10.96M(-1.9%) | -$52.87M(+5.0%) |
| Mar 2013 | - | -$10.75M(+36.3%) | -$55.67M(+13.4%) |
| Dec 2012 | -$64.28M(-87.4%) | -$16.87M(-18.0%) | -$64.28M(-5.5%) |
| Sep 2012 | - | -$14.30M(-3.9%) | -$60.91M(-1.4%) |
| Jun 2012 | - | -$13.76M(+28.9%) | -$60.06M(-41.1%) |
| Mar 2012 | - | -$19.36M(-43.3%) | -$42.57M(-24.1%) |
| Dec 2011 | -$34.30M(+24.4%) | -$13.50M(-0.4%) | -$34.30M(-21.8%) |
| Sep 2011 | - | -$13.44M(-459.6%) | -$28.17M(-6.9%) |
| Jun 2011 | - | $3.74M(+133.7%) | -$26.34M(+40.0%) |
| Mar 2011 | - | -$11.09M(-50.4%) | -$43.88M(+3.3%) |
| Dec 2010 | -$45.39M(-13.0%) | -$7.38M(+36.5%) | -$45.39M(+7.3%) |
| Sep 2010 | - | -$11.62M(+15.8%) | -$48.98M(+5.5%) |
| Jun 2010 | - | -$13.79M(-9.4%) | -$51.84M(-5.9%) |
| Mar 2010 | - | -$12.60M(-14.9%) | -$48.97M(-22.0%) |
| Dec 2009 | -$40.15M(-13.5%) | -$10.97M(+24.3%) | -$40.15M(-5.0%) |
| Sep 2009 | - | -$14.48M(-32.6%) | -$38.22M(-11.2%) |
| Jun 2009 | - | -$10.92M(-188.9%) | -$34.36M(-2.1%) |
| Mar 2009 | - | -$3.78M(+58.2%) | -$33.64M(+4.9%) |
| Dec 2008 | -$35.37M(>-9900.0%) | -$9.04M(+14.9%) | -$35.37M(-5.6%) |
| Sep 2008 | - | -$10.62M(-4.2%) | -$33.51M(-82.3%) |
| Jun 2008 | - | -$10.20M(-85.1%) | -$18.38M(-55.3%) |
| Mar 2008 | - | -$5.51M(+23.2%) | -$11.84M(-7912.9%) |
| Dec 2007 | -$147.70K(-102.1%) | -$7.17M(-259.4%) | -$147.70K(-100.6%) |
| Sep 2007 | - | $4.50M(+223.2%) | $23.18M(+46.0%) |
| Jun 2007 | - | -$3.65M(-159.1%) | $15.88M(-1.1%) |
| Mar 2007 | - | $6.18M(-61.8%) | $16.06M(+126.8%) |
| Dec 2006 | $7.08M(+154.5%) | $16.16M(+677.4%) | $7.08M(+155.8%) |
| Sep 2006 | - | -$2.80M(+19.5%) | -$12.68M(+4.4%) |
| Jun 2006 | - | -$3.48M(-24.1%) | -$13.26M(-4.1%) |
| Mar 2006 | - | -$2.80M(+22.2%) | -$12.74M(+2.0%) |
| Dec 2005 | -$13.00M(-68.4%) | -$3.60M(-6.6%) | -$13.00M(-6.5%) |
| Sep 2005 | - | -$3.38M(-14.3%) | -$12.20M(-7.4%) |
| Jun 2005 | - | -$2.96M(+3.3%) | -$11.36M(-14.8%) |
| Mar 2005 | - | -$3.06M(-8.9%) | -$9.90M(-28.2%) |
| Dec 2004 | -$7.72M(>-9900.0%) | -$2.81M(-10.8%) | -$7.72M(-92.5%) |
| Sep 2004 | - | -$2.53M(-69.4%) | -$4.01M(-160.1%) |
| Jun 2004 | - | -$1.50M(-70.3%) | -$1.54M(-170.0%) |
| Mar 2004 | - | -$878.90K(-197.5%) | -$570.80K(-1046.2%) |
| Dec 2003 | -$49.70K(+10.9%) | $901.20K(+1443.1%) | -$49.80K(+95.0%) |
| Sep 2003 | - | -$67.10K(+87.2%) | -$990.50K(-6.1%) |
| Jun 2003 | - | -$526.00K(-47.0%) | -$933.90K(-132.9%) |
| Mar 2003 | - | -$357.90K(-806.1%) | -$401.00K(-619.9%) |
| Dec 2002 | -$55.80K(-62.2%) | -$39.50K(-276.2%) | -$55.70K(-243.8%) |
| Sep 2002 | - | -$10.50K(-252.2%) | -$16.20K(-184.2%) |
| Jun 2002 | - | $6900.00(+154.8%) | -$5700.00(+54.8%) |
| Mar 2002 | - | -$12.60K | -$12.60K |
| Dec 2001 | -$34.40K | - | - |
FAQ
- What is Halozyme Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Halozyme Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Halozyme Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Halozyme Therapeutics, Inc.?
- What is Halozyme Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Halozyme Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of HALO is $479.06M
What is the all-time high annual cash from operations for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high annual cash from operations is $479.06M
What is Halozyme Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, HALO annual cash from operations has changed by +$90.49M (+23.29%)
What is Halozyme Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of HALO is $99.71M
What is the all-time high quarterly cash from operations for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high quarterly cash from operations is $178.47M
What is Halozyme Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, HALO quarterly cash from operations has changed by +$43.92M (+78.71%)
What is Halozyme Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of HALO is $547.77M
What is the all-time high TTM cash from operations for Halozyme Therapeutics, Inc.?
Halozyme Therapeutics, Inc. all-time high TTM cash from operations is $547.77M
What is Halozyme Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, HALO TTM cash from operations has changed by +$127.79M (+30.43%)